Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04924985 · ClinicalTrials.gov registry record · NA

Goal-directed CPR Using Cerebral Oximetry

A NA study of Ischemia and Reperfusion Injury, sponsored by NYU Langone Health.

Active
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT04924985 is a NA study of Ischemia and Reperfusion Injury that is active but no longer recruiting, run by NYU Langone Health. The registered enrollment target is 150 participants, below the 475-participant average among 11 other Ischemia trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04924985, a NA study of Ischemia and Reperfusion Injury, is active but no longer recruiting, sponsored by NYU Langone Health.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

The proposed study is a single-center, randomized controlled pilot trial of adults who suffer in-hospital cardiac arrests. Using cerebral oxygenation and end-tidal carbon dioxide physiological targets to predict survival and neurological outcome, the impact of physiological-feedback CPR will be assessed. 150 adult patients who have a cardiac arrest event at NYU Tisch Hospital will be randomized to one of two treatment groups: (1) Physiological-Feedback CPR or (2) Non-Physiological (Audiovisual) Feedback CPR.

Interventions

  • OTHER Non-Physiological Feedback CPR
  • OTHER Physiological Feedback CPR

Study Locations (1)

New York

  • NYU Langone Health - New York

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2022-02-11
Est. Completion 2025-07-31
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT04924985

The ClinicalTrials.gov registry entry for NCT04924985 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 475-participant average among 11 other Ischemia trials with a reported enrollment target (68% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Ischemia appearing as the primary indexed condition, and to 2 interventions - of which Non-Physiological Feedback CPR is the first listed.

NCT04924985 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04924985 about?

NCT04924985 is a clinical study titled "Goal-directed CPR Using Cerebral Oximetry". The proposed study is a single-center, randomized controlled pilot trial of adults who suffer in-hospital cardiac arrests. Using cerebral oxygenation and end-tidal carbon dioxide physiological targets to predict survival and neurological outcome, the impact of physiological-feedback CPR will be asse...

What is the current status of trial NCT04924985?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2022-02-11. Estimated completion is 2025-07-31.

What conditions does trial NCT04924985 study?

This clinical trial studies the following conditions: Ischemia, Reperfusion Injury.

What interventions are being tested in trial NCT04924985?

The interventions under investigation include: Non-Physiological Feedback CPR (OTHER), Physiological Feedback CPR (OTHER).

Who is sponsoring clinical trial NCT04924985?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04924985 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ischemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.